ENTA ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/12/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-0.67
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)14.36M
Enanta Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Enanta Pharmaceuticals Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Enanta Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Enanta Pharmaceuticals Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Enanta Pharmaceuticals Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
ENTA ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
ENTA FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-3.8430.03%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)65.32M-3.42%
Enanta Pharmaceuticals Inc(ENTA) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/12/2026 | 09/2026 | -0.67/-0.51 | 14.36M/16.80M | -31.45% | -14.51% |
| 5/11/2026 | 06/2026 | -0.45/-0.49 | 17.16M/17.09M | 7.62% | 0.39% |
| 2/9/2026 | 03/2026 | -0.42/-0.81 | 18.61M/16.14M | 48.57% | 15.33% |
| 11/17/2025 | 12/2025 | -0.87/-1.02 | 15.13M/15.96M | 14.33% | -5.21% |
| 8/11/2025 | 09/2025 | -0.85/-1.28 | 18.31M/15.54M | 33.10% | 17.86% |
| 5/12/2025 | 06/2025 | -1.06/-1.14 | 14.93M/15.95M | 6.66% | -6.43% |
| 2/10/2025 | 03/2025 | -1.05/-1.35 | 16.96M/17.25M | 22.42% | -1.68% |
| 11/25/2024 | 12/2024 | -1.36/-1.16 | 14.61M/17.93M | -17.24% | -18.54% |